Medipharm Labs Corp T.LABS

Alternate Symbol(s): MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.

TSX:LABS - Post by User

Medipharm Labs Corp > When President Biden along with the FDA and NIH asked DEA

<< Previous

Bullboard Posts

Next >>

Comment by subaru1ion Feb 12, 2024 9:06pm

85 Views

Post# 35876669

RE:When President Biden along with the FDA and NIH asked DEA

PS: There are countless scientific papers on the pharmaceutical applications of cannabinoids and the diseases they can be effective against. It doesn't take much to do a simple Google search to find all of those publications be it you or me or 'smart money' that can afford to pay thousands of dollars for market research reports.

I'm a seller between $10 to $20 not because I'm greedy but because that is where I think the market will value this stock once the news is out and the applications.

<< Previous

Bullboard Posts

Next >>

Full Circle Lithium goes global with its battery fire-fighter